Observational studyOphthalmology. Retina2024

Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study.

Cindy X Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.